Dosidal · Switzerland

Zerbaxa, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:65472 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 65472
atc: J01DI54
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2016-03-03
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: J01DI54
authorisation_number: 65472
form: PULPA
holder: MSD Merck Sharp & Dohme AG
holder_partner_nr: 1003060
it_number: 08.01.3.
name: Zerbaxa, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
I592A0brejFP1LBeclLZbhP69fbFLyjnVopMV5VtQZ-cpekIKfAENFchuthmQhDBgN4H0bmQM5Wf0aEXUR06Bw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:65472 · Related records in other markets · Dosidal